Federal Register #2026-08512

CMS Announces Rechartering and New Membership for Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests

This notice announces the rechartering and new membership of the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests (CDLTs) under the Centers for Medicare & Medicaid Services (CMS), part of the Department of Health and Human Services. - Government Buyer: - Department of Health and Human Services - Centers for Medicare & Medicaid Services (CMS) - Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests - Purpose and Activities: - The Panel provides advisory services to the Secretary of HHS and the CMS Administrator - Focuses on payment rates, coverage, and policy issues for clinical diagnostic laboratory tests - Reviews and makes recommendations on new and reconsidered test codes for the Clinical Laboratory Fee Schedule (CLFS) for Calendar Year 2027 - Membership and Meetings: - Five new members appointed with expertise in laboratory science and health economics - Public meetings scheduled for mid-2026, with both in-person and virtual participation options - Products/Services: - No products or commercial services are being procured or awarded - No OEMs or vendors are referenced in this notice - Locations: - Meetings and activities will take place at CMS Headquarters in Baltimore, Maryland, and virtually - Notable Requirements: - The notice is informational, relating to advisory activities and public engagement, not procurement

Description

This notice announces the rechartering of the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests, the appointment of five new members, and the scheduling of upcoming public meetings on July 14-15, 2026, and additional virtual meetings in June and September 2026. The Panel advises the Secretary of the Department of Health and Human Services and the Administrator of the Centers for Medicare & Medicaid Services on issues related to clinical diagnostic laboratory tests, including payment rates and coverage. The meetings will discuss new and reconsidered test codes for the Clinical Laboratory Fee Schedule for Calendar Year 2027 and other related issues. Public participation is allowed both in-person and virtually, with registration required for in-person attendance.

View original listing